Core Viewpoint - Atmos Energy Corporation (ATO) is set to release its third-quarter fiscal 2025 results on August 6, with an earnings surprise of 3.8% in the previous quarter [1] Group 1: Factors Impacting Q3 Earnings - Strategic investments in modernizing transmission and distribution systems are expected to enhance service reliability and positively impact the bottom line [2] - An expanding customer base and the implementation of new rates in service regions are anticipated to contribute positively to earnings [3] - Higher distribution revenues and lower interest expenses are likely to support ATO's quarterly results [3] - Increased operation and maintenance expenses, along with higher depreciation and amortization, may negatively affect the bottom line [4] Group 2: Earnings Expectations - The Zacks Consensus Estimate for earnings is $1.17 per share, reflecting a year-over-year increase of 8.3% [5] - The revenue estimate stands at $940.91 million, indicating a year-over-year improvement of 34.1% [5] Group 3: Earnings Prediction Model - The current model does not predict an earnings beat for Atmos Energy, with an Earnings ESP of 0.00% and a Zacks Rank of 3 [6][7] Group 4: Industry Comparisons - New Jersey Resources (NJR) is expected to report an earnings beat with an Earnings ESP of +11.77% and a Zacks Rank of 3 [8] - ONE Gas (OGS) is also likely to achieve an earnings beat with an Earnings ESP of +3.22% and a Zacks Rank of 2 [10] - MDU Resources Group (MDU) is projected to report an earnings beat with an Earnings ESP of +20% and a Zacks Rank of 2 [11]

Core Insights - Amarin Corporation (AMRN) reported a narrower loss of $0.03 per share for Q2 2025, compared to the Zacks Consensus Estimate of a loss of $0.66 per share, and break-even earnings in the same quarter last year [1][7] - Total revenues for Q2 2025 were $72.7 million, exceeding the Zacks Consensus Estimate of $46 million, and representing an 8% increase from the previous year, driven by higher licensing and royalty revenues [2][7] Financial Performance - Adjusted earnings, excluding stock-based compensation, licensing fees, and restructuring expenses, were $0.04 per share, up from $0.01 per share in the year-ago quarter [2] - Net product revenues from Vascepa, the company's sole marketed drug, were $46.6 million, a 2% decline year-over-year, with U.S. product revenues down 17% to $36.5 million due to increased generic competition [4][8] - Licensing and royalty revenues increased by 31% year-over-year to $26.1 million, attributed to an upfront payment from a European licensing agreement and higher royalties [8] Market Reaction - Shares of Amarin rose by 2.2% on July 30 following the better-than-expected results, with the stock up 54.3% year-to-date compared to a 1% rise in the industry [3] Strategic Developments - In June 2025, Amarin signed a long-term exclusive licensing agreement with Recordati to commercialize Vazkepa in 59 European countries, receiving an upfront payment of $25 million and potential milestone payments of up to $150 million [10][11] - A global restructuring initiative is expected to save approximately $70 million over the next 12 months, which is anticipated to enhance European growth [7][11] Cash Position - As of the end of Q2 2025, Amarin had cash and investments totaling $298.7 million, an increase from $281.8 million as of March 31, 2025 [9]

Core Insights - Fortive (FTV) reported a revenue of $1.02 billion for the quarter ended June 2025, marking a year-over-year decline of 34.5% and an EPS of $0.58 compared to $0.93 a year ago [1] - The reported revenue exceeded the Zacks Consensus Estimate of $1.01 billion by 0.85%, while the EPS fell short of the consensus estimate of $0.60 by 3.33% [1] Financial Performance Metrics - Advanced Healthcare Solutions generated sales of $319.5 million, slightly above the estimated $319.3 million, reflecting a year-over-year decline of 1.3% [4] - Intelligent Operating Solutions reported sales of $675.7 million, below the estimated $689.46 million, with a year-over-year change of -0.2% [4] - Adjusted Operating Profit (Non-GAAP) for Intelligent Operating Solutions was $223.7 million, exceeding the average estimate of $222.26 million [4] - Adjusted Operating Profit (Non-GAAP) for Advanced Healthcare Solutions was $80.8 million, surpassing the estimated $75.14 million [4] - Operating Profit for Advanced Healthcare Solutions was $39.1 million, above the average estimate of $36.77 million [4] - Operating Profit for Intelligent Operating Solutions was $166.7 million, below the average estimate of $179.96 million [4] - Operating Profit for Other segments was -$76.8 million, significantly worse than the average estimate of -$30.83 million [4] Stock Performance - Fortive's shares have returned -4.2% over the past month, contrasting with the Zacks S&P 500 composite's increase of +3.4% [3] - The stock currently holds a Zacks Rank 5 (Strong Sell), indicating potential underperformance relative to the broader market in the near term [3]

Group 1 - LENZ Therapeutics, Inc. reported a quarterly loss of $0.53 per share, which was better than the Zacks Consensus Estimate of a loss of $0.58, representing an earnings surprise of +8.62% [1] - The company posted revenues of $5 million for the quarter ended June 2025, in line with the Zacks Consensus Estimate, compared to zero revenues a year ago [2] - LENZ Therapeutics shares have increased approximately 9.7% since the beginning of the year, outperforming the S&P 500's gain of 8.3% [3] Group 2 - The earnings outlook for LENZ Therapeutics will be crucial for investors, as it includes current consensus earnings expectations for upcoming quarters [4] - The estimate revisions trend for LENZ Therapeutics was favorable ahead of the earnings release, resulting in a Zacks Rank 2 (Buy) for the stock, indicating expected outperformance in the near future [6] - The current consensus EPS estimate for the upcoming quarter is -$0.70 on revenues of $5.63 million, and -$2.72 on revenues of $8.8 million for the current fiscal year [7] Group 3 - The Medical - Biomedical and Genetics industry, to which LENZ Therapeutics belongs, is currently in the top 37% of over 250 Zacks industries, suggesting a favorable outlook for stocks in this sector [8]

Core Viewpoint - VICI Properties Inc. is expected to report growth in revenues and adjusted funds from operations (AFFO) per share for the second quarter of 2025, with a consensus estimate of 60 cents per share, reflecting a 5.26% increase from the previous year [1][7]. Group 1: Financial Performance - The Zacks Consensus Estimate for quarterly revenues is projected at $996.07 million, indicating a 4.08% growth compared to the same quarter last year [4][9]. - The income from sales-type leases is estimated at $530.83 million, showing an increase from both the previous quarter and the year-ago quarter [5]. - Income from lease financing receivables and loans is expected to reach $436.44 million, up from $426.48 million in the previous quarter and $413.74 million in the year-ago period [5]. Group 2: Market Dynamics - The performance of VICI Properties in the second quarter is anticipated to be positively influenced by the resurgence in demand for its gaming and hospitality venues [2][3]. - Strong partnerships with top-tier experiential operators and long-term triple-net leases are likely to contribute to stable revenue generation [3][9]. - The company has diversified its portfolio beyond gaming, including investments in non-gaming experiential assets like Chelsea Piers and Bowlero, which supports its growth strategy [4][9]. Group 3: Analyst Sentiment - Analysts have shown confidence in VICI's performance, as the consensus estimate for AFFO per share has been revised upward by one cent over the past month [7]. - The company currently has an Earnings ESP of +15.43% and a Zacks Rank of 3, indicating a potential for an earnings surprise [10].

Core Viewpoint - CMS Energy Corp. is set to release its second-quarter 2025 results on July 31, with expectations of moderate revenue growth and potential earnings challenges due to weather-related costs and operational expenses [1][9]. Factors Influencing Q2 Results - Cooler-than-normal temperatures in April and May, followed by above-average temperatures in June, are expected to have a moderate impact on the company's top-line performance [2]. - Recent favorable rate hikes are likely to have positively influenced overall revenues for the quarter [2]. - Anticipated solid sales growth, cost reduction efforts, favorable returns from prior capital investments, and benefits from renewable projects are expected to boost second-quarter earnings [3]. Potential Challenges - Severe weather conditions, including heavy rainfall and tornadoes, may have caused infrastructure damage, increasing service restoration expenses and negatively impacting earnings [4]. - Higher operating and maintenance costs from the execution of the electric reliability roadmap may also exert downward pressure on quarterly earnings [4]. Q2 Financial Expectations - The Zacks Consensus Estimate for sales is projected at $1.69 billion, reflecting a year-over-year growth of 5.1% [5]. - The consensus estimate for earnings is set at 67 cents per share, indicating a year-over-year increase of 1.5% [5]. Earnings Prediction Model - The earnings prediction model suggests a potential earnings beat for CMS, supported by a positive Earnings ESP of +4.10% and a Zacks Rank of 3 (Hold) [6][7]. Industry Comparisons - Other industry players, such as American Electric Power, IDACORP Inc., and Xcel Energy Inc., are also expected to report earnings with positive growth indicators, showcasing a competitive landscape within the sector [10][11][12].

Company Performance - Brunswick reported quarterly earnings of $1.16 per share, exceeding the Zacks Consensus Estimate of $0.89 per share, but down from $1.8 per share a year ago, representing an earnings surprise of +30.34% [1] - The company posted revenues of $1.45 billion for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 18.33%, compared to revenues of $1.44 billion a year ago [2] - Over the last four quarters, Brunswick has surpassed consensus EPS estimates three times and topped consensus revenue estimates four times [2] Future Outlook - The sustainability of Brunswick's stock price movement will depend on management's commentary during the earnings call and future earnings expectations [3][4] - The current consensus EPS estimate for the upcoming quarter is $1.07 on revenues of $1.35 billion, and for the current fiscal year, it is $3.03 on revenues of $5.05 billion [7] - The estimate revisions trend for Brunswick was favorable ahead of the earnings release, resulting in a Zacks Rank 1 (Strong Buy) for the stock, indicating expected outperformance in the near future [6] Industry Context - The Leisure and Recreation Products industry, to which Brunswick belongs, is currently in the bottom 27% of over 250 Zacks industries, which may impact stock performance [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, suggesting that tracking these revisions can be beneficial for investors [5]

Group 1 - T-Mobile reported quarterly earnings of $2.84 per share, exceeding the Zacks Consensus Estimate of $2.69 per share, and up from $2.49 per share a year ago, representing an earnings surprise of +5.58% [1][2] - The company achieved revenues of $21.13 billion for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 0.77%, and an increase from $19.77 billion year-over-year [2] - T-Mobile has consistently surpassed consensus EPS estimates over the last four quarters, indicating strong performance [2][6] Group 2 - The stock's immediate price movement will depend on management's commentary during the earnings call and future earnings expectations [3][4] - T-Mobile shares have increased approximately 5.7% since the beginning of the year, compared to a 7.3% gain for the S&P 500 [3] - The current consensus EPS estimate for the upcoming quarter is $2.75 on revenues of $21.41 billion, and for the current fiscal year, it is $10.59 on revenues of $86.38 billion [7] Group 3 - The Zacks Industry Rank indicates that the Wireless National industry is currently in the bottom 28% of over 250 Zacks industries, which may impact T-Mobile's stock performance [8] - Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]

Core Insights - CBRE Group, Inc. is set to announce its Q2 2025 earnings on July 29, showcasing its leadership in real estate services with a comprehensive suite of offerings [1] - The company reported a 6.2% earnings surprise in the last quarter, with a net revenue growth of 17%, closely aligning with an 18% increase in transactional businesses [2] Financial Performance - Over the past four quarters, CBRE has consistently surpassed the Zacks Consensus Estimate, with an average earnings beat of 10.4% [3] - The Zacks Consensus Estimate for Q2 revenues is $9.36 billion, indicating an 11.6% year-over-year increase, while the EPS estimate has slightly decreased to $1.05, still reflecting a 29.6% year-over-year growth [7][8] Business Strategy and Market Trends - CBRE is focusing on building a balanced operating model with a shift towards contractual revenues, which is expected to support performance [3] - The demand for outsourcing services is providing significant growth opportunities, particularly in facilities management across key sectors like technology, industrial, data centers, and healthcare [4] - The company is investing in technology to enhance operational efficiency and client solutions, which is likely aiding in navigating current market challenges [5] Market Conditions - Despite a gradual recovery in the Advisory Services segment, ongoing macroeconomic uncertainties and elevated interest rates are impacting commercial real estate transaction activities [6][8]

Group 1: Earnings Performance - Genuine Parts reported quarterly earnings of $2.1 per share, exceeding the Zacks Consensus Estimate of $2.08 per share, but down from $2.44 per share a year ago, representing an earnings surprise of +0.96% [1] - The company posted revenues of $6.16 billion for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 0.81% and up from $5.96 billion year-over-year [2] - Over the last four quarters, Genuine Parts has surpassed consensus EPS estimates three times [2] Group 2: Stock Performance and Outlook - Genuine Parts shares have increased by approximately 6.1% since the beginning of the year, compared to the S&P 500's gain of 7.2% [3] - The current consensus EPS estimate for the upcoming quarter is $2.09 on revenues of $6.15 billion, and for the current fiscal year, it is $7.81 on revenues of $24.13 billion [7] - The estimate revisions trend for Genuine Parts was mixed ahead of the earnings release, resulting in a Zacks Rank 3 (Hold) for the stock, indicating expected performance in line with the market [6] Group 3: Industry Context - The Automotive - Retail and Wholesale - Parts industry is currently in the top 40% of over 250 Zacks industries, suggesting a favorable outlook [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]